Cancer research has taken a step forward due to a technique evolved by an Israeli woman scientist that promises the early detection of cancer.
LV & SV Sign "Hadassah Hebrew University Medical Centre"
SCU Doctor Chloe Tal PAN to Assistant Miss Miriam Halparin PAN again to Dr. Tal carrying out experiment with pipette
CU Dr. Tal
SCU Dr. Tal putting liquid into test tubes from pipette
SV Dr. Tal sucking liquid into pipette and holding up to light
Initials MF/DW/PS/VH/1127 MF/DW/VH/1143
Script is copyright Reuters Limited. All rights reserved
Background: Cancer research has taken a step forward due to a technique evolved by an Israeli woman scientist that promises the early detection of cancer. Dr Chlos Tal, of the Hadassah-Hebrew University Medical Centre in Jerusalem, may have found a universal, simple test for the fatal disease that has eluded scientists for fifty years.
Dr. Tal has found that the presence of a certain protein in the blood stream indicates either pregnancy, or cancer. The first report of her work, which was published in Israel last December, has been greeted throughout the scientific world with great interest.
The questions now being asked are whether the test will be confirmed when used by thousands of people. and whether it applies to all cancers. Dr. Tal, who answers the second question affirmatively, is preparing now a large-scale application of the test to judge the first.
Dr. Tal has labelled the protein T - Globulin. She suspects that all people are exposed all the time to cancerous cell mutations, but only a certain number get the disease. This, she believes, is due to an immunological response. When the response is not functioning properly, T-Globulin is found in the blood stream, and cancer is diagnosed. Of 356 positive results to her tests in Jerusalem, 350 patients were found to have cancer, three were non-verified and three patients were pregnant women.